Understanding the Intersections between Metabolism and Cancer Biology

Cell

Volumn 168, Issue 4, 2017, Pages 657-669

  Vander Heiden, Matthew G ^a,b   DeBerardinis, Ralph J ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AERASE; AG 120; AG 881; ANTINEOPLASTIC AGENT; ASPARAGINASE; AZATHIOPRINE; BAY 1436032; CB 839; CYTARABINE; ENASIDENIB; EPACADOSTAT; FLUDARABINE; FLUOROURACIL; FT 2102; GEMCITABINE; HYDROXYUREA; IDH 305; LEFLUNOMIDE; METHOTREXATE; PEGARGIMINASE; PEMETREXED; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TVB 2640; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NUCLEOTIDE;

AMINO ACID METABOLISM; BIOLOGY; CANCER CELL; CANCER GROWTH; CELL LINEAGE; CELL METABOLISM; CELL PROLIFERATION; CITRIC ACID CYCLE; CLASSIFICATION; CLINICAL TRIAL (TOPIC); DRUG INDICATION; GENE MUTATION; HUMAN; MALIGNANT NEOPLASM; METASTASIS; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE METABOLISM; NUTRIENT AVAILABILITY; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TRANSFORMED CELL; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; CELL TRANSFORMATION; METABOLISM; NEOPLASM; PATHOLOGY;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CITRIC ACID CYCLE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NADP; NEOPLASMS; NUCLEOTIDES;

EID: 85012011397     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.12.039     Document Type: Review

References (133)

1. Aird, K.M., Zhang, G., Li, H., Tu, Z., Bitler, B.G., Garipov, A., Wu, H., Wei, Z., Wagner, S.N., Herlyn, M., Zhang, R., Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep. 3 (2013), 1252–1265.
2. Altman, B.J., Stine, Z.E., Dang, C.V., From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16 (2016), 619–634.
3. Andronesi, O.C., Kim, G.S., Gerstner, E., Batchelor, T., Tzika, A.A., Fantin, V.R., Vander Heiden, M.G., Sorensen, A.G., Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci. Transl. Med., 4, 2012, 116ra4.
4. Andrzejewski, S., Gravel, S.P., Pollak, M., St-Pierre, J., Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab., 2, 2014, 12.
5. Bao, X.R., Ong, S.E., Goldberger, O., Peng, J., Sharma, R., Thompson, D.A., Vafai, S.B., Cox, A.G., Marutani, E., Ichinose, F., et al. Mitochondrial dysfunction remodels one-carbon metabolism in human cells. eLife, 5, 2016, 5.
6. Baysal, B.E., Ferrell, R.E., Willett-Brozick, J.E., Lawrence, E.C., Myssiorek, D., Bosch, A., van der Mey, A., Taschner, P.E., Rubinstein, W.S., Myers, E.N., et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287 (2000), 848–851.
7. Bertout, J.A., Patel, S.A., Simon, M.C., The impact of O2 availability on human cancer. Nat. Rev. Cancer 8 (2008), 967–975.
8. Birsoy, K., Possemato, R., Lorbeer, F.K., Bayraktar, E.C., Thiru, P., Yucel, B., Wang, T., Chen, W.W., Clish, C.B., Sabatini, D.M., Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508 (2014), 108–112.
9. Birsoy, K., Wang, T., Chen, W.W., Freinkman, E., Abu-Remaileh, M., Sabatini, D.M., An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162 (2015), 540–551.
10. Bittar, P.G., Charnay, Y., Pellerin, L., Bouras, C., Magistretti, P.J., Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J. Cereb. Blood Flow Metab. 16 (1996), 1079–1089.
11. Boros, L.G., Torday, J.S., Lim, S., Bassilian, S., Cascante, M., Lee, W.N., Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res. 60 (2000), 1183–1185.
12. Boudreau, A., Purkey, H.E., Hitz, A., Robarge, K., Peterson, D., Labadie, S., Kwong, M., Hong, R., Gao, M., Del Nagro, C., et al. Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nat. Chem. Biol. 12 (2016), 779–786.
13. Brand, A., Singer, K., Koehl, G.E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24 (2016), 657–671.
14. Burtscher, M., Effects of living at higher altitudes on mortality: a narrative review. Aging Dis. 5 (2013), 274–280.
15. Buzzai, M., Jones, R.G., Amaravadi, R.K., Lum, J.J., DeBerardinis, R.J., Zhao, F., Viollet, B., Thompson, C.B., Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 67 (2007), 6745–6752.
16. Cairns, R.A., Mak, T.W., The current state of cancer metabolism. Nat. Rev. Cancer 16 (2016), 613–614.
17. Chang, C.H., Qiu, J., O'Sullivan, D., Buck, M.D., Noguchi, T., Curtis, J.D., Chen, Q., Gindin, M., Gubin, M.M., van der Windt, G.J., et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162 (2015), 1229–1241.
18. Chen, C., Liu, Y., Lu, C., Cross, J.R., Morris, J.P. 4th, Shroff, A.S., Ward, P.S., Bradner, J.E., Thompson, C., Lowe, S.W., Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition. Genes Dev. 27 (2013), 1974–1985.
19. Cheng, T., Sudderth, J., Yang, C., Mullen, A.R., Jin, E.S., Matés, J.M., DeBerardinis, R.J., Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc. Natl. Acad. Sci. USA 108 (2011), 8674–8679.
20. Choi, C., Ganji, S.K., DeBerardinis, R.J., Hatanpaa, K.J., Rakheja, D., Kovacs, Z., Yang, X.L., Mashimo, T., Raisanen, J.M., Marin-Valencia, I., et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat. Med. 18 (2012), 624–629.
21. Cocco, P., Does G6PD deficiency protect against cancer? A critical review. J. Epidemiol. Community Health 41 (1987), 89–93.
22. Coloff, J.L., Murphy, J.P., Braun, C.R., Harris, I.S., Shelton, L.M., Kami, K., Gygi, S.P., Selfors, L.M., Brugge, J.S., Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells. Cell Metab. 23 (2016), 867–880.
23. Commisso, C., Davidson, S.M., Soydaner-Azeloglu, R.G., Parker, S.J., Kamphorst, J.J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J.A., Thompson, C.B., et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497 (2013), 633–637.
24. Curi, R., Newsholme, P., Newsholme, E.A., Metabolism of pyruvate by isolated rat mesenteric lymphocytes, lymphocyte mitochondria and isolated mouse macrophages. Biochem. J. 250 (1988), 383–388.
25. Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462 (2009), 739–744.
26. Davidson, S.M., Jonas, O., Keibler, M.A., Hou, H.W., Luengo, A., Mayers, J.R., Wyckoff, J., Del Rosario, A.M., Whitman, M., Chin, C.R., et al. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors. Nat. Med., 2016, 10.1038/nm.4256 Published online December 26, 2016.
27. Davidson, S.M., Papagiannakopoulos, T., Olenchock, B.A., Heyman, J.E., Keibler, M.A., Luengo, A., Bauer, M.R., Jha, A.K., O'Brien, J.P., Pierce, K.A., et al. Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer. Cell Metab. 23 (2016), 517–528.
28. Dayton, T.L., Gocheva, V., Miller, K.M., Israelsen, W.J., Bhutkar, A., Clish, C.B., Davidson, S.M., Luengo, A., Bronson, R.T., Jacks, T., Vander Heiden, M.G., Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes Dev. 30 (2016), 1020–1033.
29. De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B.W., Cantelmo, A.R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154 (2013), 651–663.
30. DeBerardinis, R.J., Chandel, N.S., Fundamentals of cancer metabolism. Sci. Adv., 2, 2016, e1600200.
31. DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., Thompson, C.B., Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA 104 (2007), 19345–19350.
32. Dietrich, L.E., Okegbe, C., Price-Whelan, A., Sakhtah, H., Hunter, R.C., Newman, D.K., Bacterial community morphogenesis is intimately linked to the intracellular redox state. J. Bacteriol. 195 (2013), 1371–1380.
33. Erez, A., DeBerardinis, R.J., Metabolic dysregulation in monogenic disorders and cancer - finding method in madness. Nat. Rev. Cancer 15 (2015), 440–448.
34. Fan, J., Ye, J., Kamphorst, J.J., Shlomi, T., Thompson, C.B., Rabinowitz, J.D., Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510 (2014), 298–302.
35. Fang, M., Shen, Z., Huang, S., Zhao, L., Chen, S., Mak, T.W., Wang, X., The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 143 (2010), 711–724.
36. Fantin, V.R., St-Pierre, J., Leder, P., Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9 (2006), 425–434.
37. Fletcher, M., Ramirez, M.E., Sierra, R.A., Raber, P., Thevenot, P., Al-Khami, A.A., Sanchez-Pino, D., Hernandez, C., Wyczechowska, D.D., Ochoa, A.C., Rodriguez, P.C., l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells. Cancer Res. 75 (2015), 275–283.
38. Flier, J.S., Mueckler, M.M., Usher, P., Lodish, H.F., Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235 (1987), 1492–1495.
39. Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., Chiaradonna, F., Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLoS ONE, 4, 2009, e4715.
40. Gatenby, R.A., Gillies, R.J., Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 4 (2004), 891–899.
41. Gaude, E., Frezza, C., Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival. Nat. Commun., 7, 2016, 13041.
42. Geiger, R., Rieckmann, J.C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167 (2016), 829–842.e13.
43. Gui, D.Y., Sullivan, L.B., Luengo, A., Hosios, A.M., Bush, L.N., Gitego, N., Davidson, S.M., Freinkman, E., Thomas, C.J., Vander Heiden, M.G., Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin. Cell Metab. 24 (2016), 716–727.
44. Guo, J.Y., Teng, X., Laddha, S.V., Ma, S., Van Nostrand, S.C., Yang, Y., Khor, S., Chan, C.S., Rabinowitz, J.D., White, E., Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells. Genes Dev. 30 (2016), 1704–1717.
45. Hakimi, A.A., Reznik, E., Lee, C.H., Creighton, C.J., Brannon, A.R., Luna, A., Aksoy, B.A., Liu, E.M., Shen, R., Lee, W., et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell 29 (2016), 104–116.
46. Harris, I.S., Treloar, A.E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K.C., Yung, K.Y., Brenner, D., Knobbe-Thomsen, C.B., Cox, M.A., et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27 (2015), 211–222.
47. Henrich, F.C., Singer, K., Poller, K., Bernhardt, L., Strobl, C.D., Limm, K., Ritter, A.P., Gottfried, E., Völkl, S., Jacobs, B., et al. Suppressive effects of tumor cell-derived 5′-deoxy-5′-methylthioadenosine on human T cells. OncoImmunology, 5, 2016, e1184802.
48. Hensley, C.T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. Metabolic heterogeneity in human lung tumors. Cell 164 (2016), 681–694.
49. Ho, P.C., Bihuniak, J.D., Macintyre, A.N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.C., Cui, G., Micevic, G., Perales, J.C., et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162 (2015), 1217–1228.
50. Hosios, A.M., Hecht, V.C., Danai, L.V., Johnson, M.O., Rathmell, J.C., Steinhauser, M.L., Manalis, S.R., Vander Heiden, M.G., Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell 36 (2016), 540–549.
51. Howell, J.J., Ricoult, S.J., Ben-Sahra, I., Manning, B.D., A growing role for mTOR in promoting anabolic metabolism. Biochem. Soc. Trans. 41 (2013), 906–912.
52. Hu, J., Locasale, J.W., Bielas, J.H., O'Sullivan, J., Sheahan, K., Cantley, L.C., Vander Heiden, M.G., Vitkup, D., Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat. Biotechnol. 31 (2013), 522–529.
53. Hung, Y.P., Albeck, J.G., Tantama, M., Yellen, G., Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor. Cell Metab. 14 (2011), 545–554.
54. Israelsen, W.J., Dayton, T.L., Davidson, S.M., Fiske, B.P., Hosios, A.M., Bellinger, G., Li, J., Yu, Y., Sasaki, M., Horner, J.W., et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155 (2013), 397–409.
55. Israelsen, W.J., Vander Heiden, M.G., Pyruvate kinase: Function, regulation and role in cancer. Semin. Cell Dev. Biol. 43 (2015), 43–51.
56. Janzer, A., German, N.J., Gonzalez-Herrera, K.N., Asara, J.M., Haigis, M.C., Struhl, K., Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells. Proc. Natl. Acad. Sci. USA 111 (2014), 10574–10579.
57. Jiang, L., Xiao, L., Sugiura, H., Huang, X., Ali, A., Kuro-o, M., Deberardinis, R.J., Boothman, D.A., Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition. Oncogene 34 (2015), 3908–3916.
58. Jiang, L., Shestov, A.A., Swain, P., Yang, C., Parker, S.J., Wang, Q.A., Terada, L.S., Adams, N.D., McCabe, M.T., Pietrak, B., et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532 (2016), 255–258.
59. Kaelin, W.G. Jr., McKnight, S.L., Influence of metabolism on epigenetics and disease. Cell 153 (2013), 56–69.
60. Kamphorst, J.J., Nofal, M., Commisso, C., Hackett, S.R., Lu, W., Grabocka, E., Vander Heiden, M.G., Miller, G., Drebin, J.A., Bar-Sagi, D., et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 75 (2015), 544–553.
61. Kats, L.M., Reschke, M., Taulli, R., Pozdnyakova, O., Burgess, K., Bhargava, P., Straley, K., Karnik, R., Meissner, A., Small, D., et al. Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance. Cell Stem Cell 14 (2014), 329–341.
62. Koppenol, W.H., Bounds, P.L., Dang, C.V., Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11 (2011), 325–337.
63. Krall, A.S., Xu, S., Graeber, T.G., Braas, D., Christofk, H.R., Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nat. Commun., 7, 2016, 11457.
64. Kryukov, G.V., Wilson, F.H., Ruth, J.R., Paulk, J., Tsherniak, A., Marlow, S.E., Vazquez, F., Weir, B.A., Fitzgerald, M.E., Tanaka, M., et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science 351 (2016), 1214–1218.
65. Kuehne, A., Emmert, H., Soehle, J., Winnefeld, M., Fischer, F., Wenck, H., Gallinat, S., Terstegen, L., Lucius, R., Hildebrand, J., Zamboni, N., Acute activation of oxidative pentose phosphate pathway as first-line response to oxidative stress in human skin cells. Mol. Cell 59 (2015), 359–371.
66. Le, A., Cooper, C.R., Gouw, A.M., Dinavahi, R., Maitra, A., Deck, L.M., Royer, R.E., Vander Jagt, D.L., Semenza, G.L., Dang, C.V., Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc. Natl. Acad. Sci. USA 107 (2010), 2037–2042.
67. LeBleu, V.S., O'Connell, J.T., Gonzalez Herrera, K.N., Wikman, H., Pantel, K., Haigis, M.C., de Carvalho, F.M., Damascena, A., Domingos Chinen, L.T., Rocha, R.M., et al. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 16 (2014), 992–1003 1–15.
68. Lewis, C.A., Parker, S.J., Fiske, B.P., McCloskey, D., Gui, D.Y., Green, C.R., Vokes, N.I., Feist, A.M., Vander Heiden, M.G., Metallo, C.M., Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell 55 (2014), 253–263.
69. Li, B., Qiu, B., Lee, D.S., Walton, Z.E., Ochocki, J.D., Mathew, L.K., Mancuso, A., Gade, T.P., Keith, B., Nissim, I., Simon, M.C., Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513 (2014), 251–255.
70. Loayza-Puch, F., Rooijers, K., Buil, L.C., Zijlstra, J., Oude Vrielink, J.F., Lopes, R., Ugalde, A.P., van Breugel, P., Hofland, I., Wesseling, J., et al. Tumour-specific proline vulnerability uncovered by differential ribosome codon reading. Nature 530 (2016), 490–494.
71. Locasale, J.W., Grassian, A.R., Melman, T., Lyssiotis, C.A., Mattaini, K.R., Bass, A.J., Heffron, G., Metallo, C.M., Muranen, T., Sharfi, H., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43 (2011), 869–874.
72. Losman, J.A., Kaelin, W.G. Jr., What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 27 (2013), 836–852.
73. Lunt, S.Y., Muralidhar, V., Hosios, A.M., Israelsen, W.J., Gui, D.Y., Newhouse, L., Ogrodzinski, M., Hecht, V., Xu, K., Acevedo, P.N., et al. Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol. Cell 57 (2015), 95–107.
74. Maddocks, O.D., Berkers, C.R., Mason, S.M., Zheng, L., Blyth, K., Gottlieb, E., Vousden, K.H., Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493 (2013), 542–546.
75. Maher, E.A., Marin-Valencia, I., Bachoo, R.M., Mashimo, T., Raisanen, J., Hatanpaa, K.J., Jindal, A., Jeffrey, F.M., Choi, C., Madden, C., et al. Metabolism of [U-13 C]glucose in human brain tumors in vivo. NMR Biomed. 25 (2012), 1234–1244.
76. Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.L., Rajagopalan, K.N., Maddie, M., Vemireddy, V., Zhao, Z., et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab. 15 (2012), 827–837.
77. Marjon, K., Cameron, M.J., Quang, P., Clasquin, M.F., Mandley, E., Kunii, K., McVay, M., Choe, S., Kernytsky, A., Gross, S., et al. MTAP deletions in cancer create vulnerability to targeting of the MAT2A/PRMT5/RIOK1 axis. Cell Rep. 15 (2016), 574–587.
78. Mavrakis, K.J., McDonald, E.R. 3rd, Schlabach, M.R., Billy, E., Hoffman, G.R., deWeck, A., Ruddy, D.A., Venkatesan, K., Yu, J., McAllister, G., et al. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5. Science 351 (2016), 1208–1213.
79. Mayers, J.R., Torrence, M.E., Danai, L.V., Papagiannakopoulos, T., Davidson, S.M., Bauer, M.R., Lau, A.N., Ji, B.W., Dixit, P.D., Hosios, A.M., et al. Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers. Science 353 (2016), 1161–1165.
80. Meiser, J., Tumanov, S., Maddocks, O., Labuschagne, C.F., Athineos, D., Van Den Broek, N., Mackay, G.M., Gottlieb, E., Blyth, K., Vousden, K., et al. Serine one-carbon catabolism with formate overflow. Sci. Adv., 2, 2016, e1601273.
81. Michelakis, E.D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E., Maguire, C., Gammer, T.L., Mackey, J.R., Fulton, D., et al. Metabolic modulation of glioblastoma with dichloroacetate. Sci. Transl. Med., 2, 2010, 31ra34.
82. Muller, A.J., DuHadaway, J.B., Donover, P.S., Sutanto-Ward, E., Prendergast, G.C., Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11 (2005), 312–319.
83. Muller, F.L., Colla, S., Aquilanti, E., Manzo, V.E., Genovese, G., Lee, J., Eisenson, D., Narurkar, R., Deng, P., Nezi, L., et al. Passenger deletions generate therapeutic vulnerabilities in cancer. Nature 488 (2012), 337–342.
84. Navarro, P., Bueno, M.J., Zagorac, I., Mondejar, T., Sanchez, J., Mourón, S., Muñoz, J., Gómez-López, G., Jimenez-Renard, V., Mulero, F., et al. Targeting tumor mitochondrial metabolism overcomes resistance to antiangiogenics. Cell Rep. 15 (2016), 2705–2718.
85. 13C]pyruvate. Sci. Transl. Med., 5, 2013, 198ra108.
86. Palm, W., Park, Y., Wright, K., Pavlova, N.N., Tuveson, D.A., Thompson, C.B., The utilization of extracellular proteins as nutrients is suppressed by mTORC1. Cell 162 (2015), 259–270.
87. Phillips, M.M., Sheaff, M.T., Szlosarek, P.W., Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges. Cancer Res. Treat. 45 (2013), 251–262.
88. Piskounova, E., Agathocleous, M., Murphy, M.M., Hu, Z., Huddlestun, S.E., Zhao, Z., Leitch, A.M., Johnson, T.M., DeBerardinis, R.J., Morrison, S.J., Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527 (2015), 186–191.
89. Platten, M., von Knebel Doeberitz, N., Oezen, I., Wick, W., Ochs, K., Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors. Front. Immunol., 5, 2015, 673.
90. Possemato, R., Marks, K.M., Shaul, Y.D., Pacold, M.E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.K., Jang, H.G., Jha, A.K., et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476 (2011), 346–350.
91. Qiu, B., Ackerman, D., Sanchez, D.J., Li, B., Ochocki, J.D., Grazioli, A., Bobrovnikova-Marjon, E., Diehl, J.A., Keith, B., Simon, M.C., HIF2α-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 5 (2015), 652–667.
92. Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., et al. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature 527 (2015), 379–383.
93. Raj, L., Ide, T., Gurkar, A.U., Foley, M., Schenone, M., Li, X., Tolliday, N.J., Golub, T.R., Carr, S.A., Shamji, A.F., et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475 (2011), 231–234.
94. Reitzer, L.J., Wice, B.M., Kennell, D., The pentose cycle. Control and essential function in HeLa cell nucleic acid synthesis. J. Biol. Chem. 255 (1980), 5616–5626.
95. Robbins, M.E., Zhao, W., Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int. J. Radiat. Biol. 80 (2004), 251–259.
96. Saha, S.K., Parachoniak, C.A., Ghanta, K.S., Fitamant, J., Ross, K.N., Najem, M.S., Gurumurthy, S., Akbay, E.A., Sia, D., Cornella, H., et al. Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer. Nature 513 (2014), 110–114.
97. Sasaki, M., Knobbe, C.B., Munger, J.C., Lind, E.F., Brenner, D., Brüstle, A., Harris, I.S., Holmes, R., Wakeham, A., Haight, J., et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488 (2012), 656–659.
98. Schafer, Z.T., Grassian, A.R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H.Y., Gao, S., Puigserver, P., Brugge, J.S., Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461 (2009), 109–113.
99. Sciacovelli, M., Gonçalves, E., Johnson, T.I., Zecchini, V.R., da Costa, A.S., Gaude, E., Drubbel, A.V., Theobald, S.J., Abbo, S.R., Tran, M.G., et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537 (2016), 544–547.
100. Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B., Gottlieb, E., Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 (2005), 77–85.
101. Sellers, K., Fox, M.P., Bousamra, M. 2nd, Slone, S.P., Higashi, R.M., Miller, D.M., Wang, Y., Yan, J., Yuneva, M.O., Deshpande, R., et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J. Clin. Invest. 125 (2015), 687–698.
102. Shackelford, D.B., Abt, E., Gerken, L., Vasquez, D.S., Seki, A., Leblanc, M., Wei, L., Fishbein, M.C., Czernin, J., Mischel, P.S., Shaw, R.J., LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell 23 (2013), 143–158.
103. Shim, H., Dolde, C., Lewis, B.C., Wu, C.S., Dang, G., Jungmann, R.A., Dalla-Favera, R., Dang, C.V., c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94 (1997), 6658–6663.
104. Shim, E.H., Livi, C.B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.Y., Ghosh, A.P., Kirkman, R., Velu, S., et al. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov. 4 (2014), 1290–1298.
105. Sonveaux, P., Végran, F., Schroeder, T., Wergin, M.C., Verrax, J., Rabbani, Z.N., De Saedeleer, C.J., Kennedy, K.M., Diepart, C., Jordan, B.F., et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118 (2008), 3930–3942.
106. Sousa, C.M., Biancur, D.E., Wang, X., Halbrook, C.J., Sherman, M.H., Zhang, L., Kremer, D., Hwang, R.F., Witkiewicz, A.K., Ying, H., et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536 (2016), 479–483.
107. Stams, W.A., den Boer, M.L., Beverloo, H.B., Meijerink, J.P., Stigter, R.L., van Wering, E.R., Janka-Schaub, G.E., Slater, R., Pieters, R., Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. Blood 101 (2003), 2743–2747.
108. Sullivan, L.B., Gui, D.Y., Hosios, A.M., Bush, L.N., Freinkman, E., Vander Heiden, M.G., Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162 (2015), 552–563.
109. Svensson, R.U., Parker, S.J., Eichner, L.J., Kolar, M.J., Wallace, M., Brun, S.N., Lombardo, P.S., Van Nostrand, J.L., Hutchins, A., Vera, L., et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models. Nat. Med. 22 (2016), 1108–1119.
110. Sykes, D.B., Kfoury, Y.S., Mercier, F.E., Wawer, M.J., Law, J.M., Haynes, M.K., Lewis, T.A., Schajnovitz, A., Jain, E., Lee, D., et al. Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia. Cell 167 (2016), 171–186.e15.
111. Szenajch, J., Wcislo, G., Jeong, J.Y., Szczylik, C., Feldman, L., The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench - a critical review. Biochim. Biophys. Acta 1806 (2010), 82–95.
112. Tateishi, K., Wakimoto, H., Iafrate, A.J., Tanaka, S., Loebel, F., Lelic, N., Wiederschain, D., Bedel, O., Deng, G., Zhang, B., et al. Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion. Cancer Cell 28 (2015), 773–784.
113. Titov, D.V., Cracan, V., Goodman, R.P., Peng, J., Grabarek, Z., Mootha, V.K., Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio. Science 352 (2016), 231–235.
114. Tomlinson, I.P., Alam, N.A., Rowan, A.J., Barclay, E., Jaeger, E.E., Kelsell, D., Leigh, I., Gorman, P., Lamlum, H., Rahman, S., et al., Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 30 (2002), 406–410.
115. Vander Heiden, M.G., Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 10 (2011), 671–684.
116. Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (2009), 1029–1033.
117. Vazquez, F., Lim, J.H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C.B., Granter, S.R., Widlund, H.R., Spiegelman, B.M., Puigserver, P., PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23 (2013), 287–301.
118. Venneti, S., Dunphy, M.P., Zhang, H., Pitter, K.L., Zanzonico, P., Campos, C., Carlin, S.D., La Rocca, G., Lyashchenko, S., Ploessl, K., et al. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo. Sci. Transl. Med., 7, 2015, 274ra17.
119. Viale, A., Pettazzoni, P., Lyssiotis, C.A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514 (2014), 628–632.
120. Weinberg, F., Hamanaka, R., Wheaton, W.W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G.M., Budinger, G.R., Chandel, N.S., Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. USA 107 (2010), 8788–8793.
121. Wenzel, C., Riefke, B., Gründemann, S., Krebs, A., Christian, S., Prinz, F., Osterland, M., Golfier, S., Räse, S., Ansari, N., et al. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions. Exp. Cell Res. 323 (2014), 131–143.
122. Wheaton, W.W., Weinberg, S.E., Hamanaka, R.B., Soberanes, S., Sullivan, L.B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G.M., Budigner, G.S., Chandel, N.S., Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife, 3, 2014, e02242.
123. White, E., Exploiting the bad eating habits of Ras-driven cancers. Genes Dev. 27 (2013), 2065–2071.
124. White, R.M., Cech, J., Ratanasirintrawoot, S., Lin, C.Y., Rahl, P.B., Burke, C.J., Langdon, E., Tomlinson, M.L., Mosher, J., Kaufman, C., et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471 (2011), 518–522.
125. Witney, T.H., James, M.L., Shen, B., Chang, E., Pohling, C., Arksey, N., Hoehne, A., Shuhendler, A., Park, J.H., Bodapati, D., et al. PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2. Sci. Transl. Med., 7, 2015, 310ra169.
126. Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26 (2012), 1326–1338.
127. Ye, X., Weinberg, R.A., Epithelial-mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 25 (2015), 675–686.
128. Ying, H., Kimmelman, A.C., Lyssiotis, C.A., Hua, S., Chu, G.C., Fletcher-Sananikone, E., Locasale, J.W., Son, J., Zhang, H., Coloff, J.L., et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149 (2012), 656–670.
129. Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., Lazebnik, Y., Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 178 (2007), 93–105.
130. Yuneva, M.O., Fan, T.W., Allen, T.D., Higashi, R.M., Ferraris, D.V., Tsukamoto, T., Matés, J.M., Alonso, F.J., Wang, C., Seo, Y., et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 15 (2012), 157–170.
131. Zhang, G., Frederick, D.T., Wu, L., Wei, Z., Krepler, C., Srinivasan, S., Chae, Y.C., Xu, X., Choi, H., Dimwamwa, E., et al. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J. Clin. Invest. 126 (2016), 1834–1856.
132. Zhang, W., Trachootham, D., Liu, J., Chen, G., Pelicano, H., Garcia-Prieto, C., Lu, W., Burger, J.A., Croce, C.M., Plunkett, W., et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat. Cell Biol. 14 (2012), 276–286.
133. Zheng, L., Cardaci, S., Jerby, L., MacKenzie, E.D., Sciacovelli, M., Johnson, T.I., Gaude, E., King, A., Leach, J.D., Edrada-Ebel, R., et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat. Commun., 6, 2015, 6001.